Cargando…
HIV Treatment-as-Prevention Research at a Crossroads
In light of changing WHO guidelines for HIV treatment, Till Bärnighausen and colleagues consider how large-scale HIV treatment-as-prevention trials can be adapted so that they can remain viable. Please see later in the article for the Editors' Summary
Autores principales: | Bärnighausen, Till, Eyal, Nir, Wikler, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043489/ https://www.ncbi.nlm.nih.gov/pubmed/24892694 http://dx.doi.org/10.1371/journal.pmed.1001654 |
Ejemplares similares
-
HIV Treatment-As-Prevention Research: Authors’ Reply
por: Bärnighausen, Till, et al.
Publicado: (2015) -
Evidence-based policymaking when evidence is incomplete: The case of HIV programme integration
por: Hontelez, Jan A. C., et al.
Publicado: (2021) -
Training and HIV-Treatment Scale-Up: Establishing an Implementation Research Agenda
por: McCarthy, Elizabeth A, et al.
Publicado: (2006) -
Male Circumcision for Prevention of HIV Transmission: What the New Data Mean for HIV Prevention in the United States
por: Sullivan, Patrick S, et al.
Publicado: (2007) -
Choices in vaccine trial design in epidemics of emerging infections
por: Kahn, Rebecca, et al.
Publicado: (2018)